Inhaler training boosts medication adherence in seniors

NCT ID NCT07381166

First seen Feb 02, 2026 · Last updated Jun 20, 2026 · Updated 24 times

Summary

This study tests whether giving elderly patients special training and reminder cards helps them use their metered-dose inhalers correctly and stick to their medication schedule. Researchers will enroll 64 people aged 65 and older who already use inhalers. The goal is to see if simple education and reminders can improve inhaler technique and medication adherence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ELDERLY (PEOPLE AGED 65 OR MORE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University

    RECRUITING

    Çanakkale, 17100, Turkey (Türkiye)

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Metered-dose inhaler training and reminder card

What this could lead to

If successful, this approach could help elderly patients use their inhalers more correctly and take their medication as prescribed, potentially improving breathing and quality of life.

What could go wrong

This is a small, early-stage study with only 64 participants, so results may not apply to all elderly patients. The intervention is educational, not a new drug, so it won't cure any lung disease.

Conditions

The condition(s) this trial relates to.

Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.